Chronic Limb-Threatening Ischemia: all 357 studies
Page 3 of 4. Open to participants first (72), then studies with results posted, then the rest; newest registration first within each.
- Treatment of No-option CLI by G-CSF-mobilized PB-MNCStatus unknownNCT03686228Not applicable
- Feasibility Clinical Trial Using the SPUR System to Demonstrate Safety and Efficacy.CompletedNCT03669458Not applicable
- Recombinant SeV-hFGF2/dF Injection for PAODStatus unknownNCT03668353Phase 1
- Laboratory, Cellular and Molecular Determinants of Clinical Success in Diabetic Patients With Critical Limb IschemiaCompletedNCT03636867
- Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease (K-ELUVIA Registry)Status unknownNCT03505931
- Diamondback in Peripheral Vascular DiseaseTerminatedNCT03455374Not applicable
- Autologous Stem Cells for the Treatment of No Option Critical Limb IschemiaCompletedNCT03455335Phase 1
- RECCORD (Recording Courses of Vascular Diseases) RegistryStatus unknownNCT03448029
- Chelation Therapy in Diabetic Patients With Critical Limb IschemiaCompletedNCT03424746Early Phase 1
- Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)Status unknownNCT03423732Phase 2/3
- ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical StudyCompletedNCT03395236Phase 4
- Open Versus Endovascular Revascularization in Patients With End-stage Renal DiseaseCompletedNCT03293589
- Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia TherapyStatus unknownNCT03239535Phase 1/2
- Autologous BMMNC Combined With HA Therapy for PAODWithdrawnNCT03214887Phase 1/2
- Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) ArteriesSuspendedNCT03175744Not applicable
- The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DMTerminatedNCT03174522Phase 3
- SCOPE CLI (Shifting Care and Outcomes for Patients With Endangered Limbs - Critical Limb Ischemia)CompletedNCT03171259
- Local Paclitaxel or Balloon Angioplasty Below the KneeStatus unknownNCT03149913Not applicable
- The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DMTerminatedNCT03111238Phase 3
- Correlation Between FlowMet™ and Other Gold Standard Assessments in the Management of Critical Limb Ischemia (CLI)WithdrawnNCT03094559Not applicable
- A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers DiseaseWithdrawnNCT03056742Phase 2
- Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic LimbsStatus unknownNCT03042572Phase 2/3
- Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial DysfunctionStatus unknownNCT03041259Phase 1/2
- Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for RevascularizationCompletedNCT03006770Phase 3
- A Long Term Follow-up Study of AMG0001 in Subjects With Critical Limb IschemiaCompletedNCT02974179
- Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)CompletedNCT02956993Phase 1
- Treatment of PAD by Platelet Lysate for Therapeutic AngiogenesisCompletedNCT02941419Phase 1/2
- Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb IschemiaStatus unknownNCT02864654Phase 1/2
- An Efficacy and Safety Study to Evaluate Ranger DEB for BTK Angioplasty in Patients With CLI (RANGER-BTK)Status unknownNCT02856230Phase 2/3
- Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study)Status unknownNCT02829151Phase 4
- BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)Active, not recruitingNCT02805023Phase 1/2
- Proteomics and Stem Cell Therapy as a New Vascularization StrategyCompletedNCT02802852Not applicable
- Plerixafor in Diabetic Wound HealingTerminatedNCT02790957Phase 2
- Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"CompletedNCT02786173
- Clinical Use of Magnetic Resonance Perfusion Imaging to Qualitatively Assess Adequate Distal Perfusion After Endovascular Revascularization in Critical Limb IschemiaCompletedNCT02646150
- Development and Validation of a Clinical Prediction Rule for Lower Limb Critical Limb Ischaemia (PREDICCMI)CompletedNCT02637492
- Neuromuscular Electrical Stimulation in Patients With Critical Limb IschaemiaTerminatedNCT02634138Not applicable
- BOLD MRI as a Surrogate of Improved Muscle Oxygenation Following Endovascular Therapy for the Treatment of CLICompletedNCT02601430Not applicable
- Elutax-SV Drug-eluting Balloons for Below-the-knee TreatmentCompletedNCT02539940
- Critical Limb Ischemia Rapid Delivery by SurgWerks-CLI Kit and VXP SystemStatus unknownNCT02538978Phase 3
- Revascularization in Nonagenarian Patients With Critical Lower Limb IschaemiaCompletedNCT02517840
- Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI)CompletedNCT02501018Phase 2
- Drug Eluting Balloons PTA in Infra-popliteal Arteries in Patients With Critical Limb IschemiaStatus unknownNCT02498080Not applicable
- A Safety and Efficacy Study of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb IschemiaWithdrawnNCT02477540Phase 1
- Phoenix Post-Approval Registry - Using the Phoenix Atherectomy SystemsCompletedNCT02475200
- Safety and Efficacy of Autologous Concentrated Bone Marrow Aspirate for Critical Limb Ischemia - Continued AccessNo longer availableNCT02474121
- Monocentric Trial: Stem Cell Emergency Life Threatening Limbs Arteriopathy (SCELTA)CompletedNCT02454231Phase 2/3
- The COPPER-B TrialCompletedNCT02395744Not applicable
- Comparison of Prevena Negative Pressure Incision Management System vs. Standard Dressing After Vascular SurgeryStatus unknownNCT02389023Not applicable
- Matrix Metalloproteinases in Patients With Critical Limb Ischemia Undergoing Surgical RevascularizationCompletedNCT02388867Not applicable
- Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb DiseaseCompletedNCT02336646Phase 1
- Clinical Trial I/II Opened, Randomized and Controlled for the Study of the Use of Stem Cells Therapy in Insulinized Diabetic Patients Type 2 With Critical Ischemia in Lower Limbs (CLI): Study of the Needs of InsulinTerminatedNCT02287974Phase 1/2
- Evaluation of Carbothera in the Treatment of Foot UlcersStatus unknownNCT02239419Not applicable
- Tack Optimized Balloon Angioplasty Below the Knee (TOBA - BTK) StudyCompletedNCT02235675Not applicable
- Evaluation of the Tissue Genesis® Icellator Cell Isolation System™ to Treat Critical Limb IschemiaStatus unknownNCT02234778Not applicable
- Drug Eluting Balloon Angioplasty Versus Nitinol Stent Implantation in the Superficial Femoral ArteryCompletedNCT02212470Phase 4
- To Evaluate the Safety and Efficacy of IM and IV Administration of Autologous ADMSCs for Treatment of CLIStatus unknownNCT02145897Phase 1/2
- Pilot Safety Study of Injectable SIS for Critical Limb IschemiaCompletedNCT02145845Not applicable
- Autologous Adipose-Derived Stromal Cell Delivered Via Intramuscular Injections for the Treatment of Critical Limb IschemiaWithdrawnNCT02099500Phase 1
- The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular InterventionCompletedNCT02096757Not applicable
- Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb IschemiaCompletedNCT02060630Not applicable
- External Compression Therapy for Secondary Prevention of Lower-Limb Loss and Cardiovascular MortalityStatus unknownNCT02054416Not applicable
- Swedish Drug-elution Trial in Peripheral Arterial DiseaseActive, not recruitingNCT02051088Not applicable
- Cook Micronized Small Intestinal Submucosa (SIS) for Critical Limb IschemiaCompletedNCT02044666Not applicable
- Safety & Feasibility Study of Tack-It Device for Vessel Dissection RepairCompletedNCT02044003Not applicable
- Drug Impregnated Bioabsorbable Stent in Asian Population Extremity Arterial Revascularization (DISAPEAR Study)CompletedNCT02043795Not applicable
- VADOplex Critical Limb Ischemia StudyStatus unknownNCT02034539Phase 2/3
- Peripheral Vascular Disease and Nerve StimulationCompletedNCT01942941Not applicable
- Evaluating the Effectiveness of Paclitaxel-eluting Balloons for Below-the-knee Angioplasty in Patients With Critical Limb IschemiaStatus unknownNCT01938872
- Registry of First-line Treatments in Patients With Critical Limb IschemiaCompletedNCT01877252
- Study to Assess Efficacy and Safety of Bone Marrow Derived Stem Cells in Patients With Critical Limb IschemiaCompletedNCT01867190Phase 2
- Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear CellsCompletedNCT01833585Phase 3
- Cryopreserved Saphenous Vein Allograft in Patients With Critical Limb Ischemia for Peripheral RevascularizationCompletedNCT01799811
- Prospective Observation Study of Outcome of Interventions for Critical IschemiaCompletedNCT01794494
- Study to Explore the Effect of Lowering Blood Viscosity in Patients With Treatment-resistant Critical Limb IschemiaCompletedNCT01758874Phase 2
- Application of Cell Regeneration Therapy With Mesenchymal Stem Cells From Adipose Tissue in Critical Chronic Ischemic Syndrome of Lower Limbs (CLI) in Nondiabetic Patients.CompletedNCT01745744Phase 2
- Impact of Critical Limb Ischemia on Long Term Cardiac Mortality in Diabetic Patients Undergoing Percutaneous Coronary RevascularizationCompletedNCT01676519
- Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cells Implantation in Patients With Critical Limb IschemiaCompletedNCT01663376Not applicable
- Self-Expanding Nitinol Stent Versus Balloon Angioplasty Alone for the Below The Knee Arteries(SENS-BTK)CompletedNCT01644487Not applicable
- Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb IschemiaTerminatedNCT01638585Phase 3
- Single Arm Study With a Nitinol Self-Expanding Paclitaxel-Eluting Stent to Treat BTK ArteriesCompletedNCT01630070Phase 2/3
- Tibiopedal Access for Crossing of Infrainguinal Artery OcclusionsCompletedNCT01609621
- Register for Patients With Diabetic Foot Syndrome and Critical Limb IschemiaTerminatedNCT01599442
- Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb IschemiaCompletedNCT01595776Phase 1/2
- Autologous Angiogenic Cell Precursors (ACPs) for the Treatment of Peripheral Artery DiseaseCompletedNCT01584986Phase 2
- Laser Atherectomy Versus Angioplasty for the Treatment of Critical Limb IschemiaCompletedNCT01579123Not applicable
- Phase I/II Trial of Endometrial Regenerative Cells (ERC) in Patients With Critical Limb IschemiaStatus unknownNCT01558908Phase 1/2
- Drug Eluting Balloon in peripherAl inTErvention For Below The Knee Angioplasty EvaluationCompletedNCT01558505Phase 4
- Safety and Efficacy Study Using Gene Therapy for Critical Limb IschemiaCompletedNCT01548378Phase 2
- A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers DiseaseCompletedNCT01484574Phase 2
- An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)CompletedNCT01483898Phase 3
- Near Infrared Spectroscopy and Transcutaneous Oxygen Pressure in Critical Limb Ischemia Before and After TreatmentCompletedNCT01459341
- Iloprost Therapy in Patients With Critical Limb IschemiaCompletedNCT01458041
- Intramuscular Mononuclear Cells and Mesenchymal Stem Cells Transplantation to Treat Chronic Critical Limb IschemiaStatus unknownNCT01456819Phase 2
- Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb IschemiaStatus unknownNCT01446055Phase 1/2
- Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Critical Limb IschemiaCompletedNCT01410331Phase 2
- Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Non-diabetic Patients With Critical Limb Ischemia (CLI).CompletedNCT01408381Phase 2
- Safety Study of Bone Marrow Cell Concentrate Prepared Using the Magellan System to Treat Critical Limb Ischemia (CLI)CompletedNCT01386216Phase 1
- Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb IschemiaCompletedNCT01351610Phase 1/2
- The ABSORB BTK (Below The Knee) Clinical InvestigationTerminatedNCT01341340Not applicable